跳到正文

Eversept Partners, LP 13F 持仓 · 2026年Q2

Eversept Partners 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 115 只证券,申报市值合计 19.28 亿美元。前几大持仓:UTHR(8.09%)、ABVX(6.32%)、EHC(5.38%)。本季前 25 大持仓中:新建仓 1 只、增持 12 只、减持 12 只。

排名代码公司市值占组合股数变动
1UTHRUNITED THERAPEUTICS CORP DEL$155.9M8.09%287,668增持
2ABVXABIVAX SA$121.8M6.32%913,880减持
3EHCENCOMPASS HEALTH CORP$103.8M5.38%1.0M增持
4ENSGENSIGN GROUP INC$96.5M5.01%602,079增持
5VERAVERA THERAPEUTICS INC$94.9M4.93%2.2M增持
6QQQINVESCO QQQ TR$72.6M3.77%98,600减持
7CLDXCELLDEX THERAPEUTICS INC NEW$66.5M3.45%1.8M减持
8SNDXSYNDAX PHARMACEUTICALS INC$61.2M3.17%2.8M减持
9BKDBROOKDALE SR LIVING INC$54.6M2.84%3.4M减持
10IONSIONIS PHARMACEUTICALS INC$52.7M2.73%664,684增持
11NTRANATERA INC$47.7M2.48%175,807减持
12TVTXTRAVERE THERAPEUTICS INC$45.4M2.35%798,973增持
13CTRECARETRUST REIT INC$43.3M2.24%1.1M新建仓
14HCAHCA HEALTHCARE INC$38.3M1.99%98,252增持
15PCVXVAXCYTE INC$36.6M1.90%629,952减持
16LQDALIQUIDIA CORPORATION$34.2M1.77%428,652减持
17CYHCOMMUNITY HEALTH SYS INC NEW$26.3M1.36%7.9M减持
18INSMINSMED INC$26.2M1.36%245,809增持
19GSKGSK PLC$25.3M1.31%481,833减持
20CHECHEMED CORP NEW$24.5M1.27%52,523增持
21LLYELI LILLY & CO$24.1M1.25%20,116增持
22GERNGERON CORP$24.0M1.24%18.7M减持
23VKTXVIKING THERAPEUTICS INC$23.5M1.22%602,922增持
24OHIOMEGA HEALTHCARE INVS INC$23.1M1.20%483,547减持
25PODDINSULET CORP$22.7M1.18%148,816增持

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR